Mandate

Global Auto Holdings Limited to acquire K.W. Bruun’s Import and Digital Businesses

September 30, 2024

Vinge advised Global Auto Holdings Limited in the acquisition of Danish automotive group K.W. Bruun’s import and digital business. In collaboration with Paul, Weiss, Rifkind, Wharton & Garrison LLP (lead counsel) and Bruun & Hjejle (Danish counsel), we have advised Global Auto Holdings Limited, a leading global auto retailer, on the acquisitions of K.W. Bruun Import A/S and K.W. Bruun NxT A/S including the acquisition financing hereof.

K.W. Bruun Import has for more than 70 years been one of the Nordic region's largest car importers and distributors of both new vehicles and OEM branded spare parts for Peugeot, Citroën, DS, Opel and Mitsubishi in Denmark and Sweden, and Fiat, Alfa Romeo, Jeep, Hongqi and Voyah in Denmark.

Global Auto Holdings Limited is an international automotive group that operates around 150 car dealerships representing a wide range of car brands. Global Auto Holdings Limited operates 164 franchise dealerships, representing more than 40 of the world’s leading car brands across the US, Canada, UK and Ireland.

The aim of this acquisition is for Global Auto Holdings Limited to become a global leader in automotive retail and related services, with a strong focus on digitalization, and positioning the company as a prominent car importer in Europe.
The transaction is expected to close in December 2024, subject to regulatory approvals.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Sara Passandideh, Ellinor Wargenbrant, Johan Cederblad, Niclas Winnberg, Kristoffer Larson, Karolina Cohrs, Jolene Reimerson, Carla Zachariasson, Gulestan Ali, Jonna Fransson, Jonna Skog, Alva Chambert, Carl Bruneheim and Julia Ulander Kull.

Read Global Auto Holdings Limited press release here.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025